University of Ibadan, University College Hospital, Nigeria is located in the Ibadan, Oyo State, Nigeria. The University began in 1948 with 104 students and has grown to a full-fledged university with a drive for excellence in postgraduate and undergraduate studies. The University College Hospital (UCH), is the country’s national leader in undergraduate and postgraduate medical education. It is the premier medical school in Nigeria and has graduated one quarter of all medical doctors in the country. In addition to undergraduate and postgraduate medical programs, in the College of Medicine of the University of Ibadan, the teaching hospital also provides facilities for Post-graduate Residency Programs in various specialties. The UCH is one of the USG PEPFAR implementing institutions in Nigeria, partnering with the Harvard Chan. It has a strong HIV research program dating back to the establishment of the Harvard and Northwestern University AIDS International Training and Research Programs (AITRP) in 2000 and 2008 respectively. Active research includes ongoing NINDS/NIH-funded collaboration on neurological complications of HIV/AIDS.
The Site Director
Dr. Adesola Ogunniyi
Professor Ogunniyi, MBBS, is a Clinician, Neurologist and Neuroepidemiologist holding faculty position at the College of Medicine, University of Ibadan. The main thrust of his research is the burden as well as the determinants of neurological disorders from cross-cultural, community perspectives. He completed a World Health Organization/Fogarty International Center/National Institute of Neurological, Communicative Disorders and Stroke (WHO-FIC-NINCDS) fellowship in Neuroepidemiology at the NIH in April 1987. In collaboration with colleagues at the Indiana School of Medicine, Indianapolis, they embarked on the first prospective, cross-cultural study of dementia which involved a comparison of African Americans and Yoruba Africans aged 65 years and above. Their findings led to the investigation of gene-environmental interactions in dementia. He serves as site-PI for the D43 training grant “Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria” and serves as co-PI on the D43 project “Medical Education Partnership Initiative for Junior Investigators” at Ibadan.
Rufus Akinyemi, MBBS, PhD, MSc, studies the public perception of stroke. As an attending Neurologist at the Federal Medical Centre, Abeokuta, Nigeria, Dr. Akinyemi served as site investigator on the INTERSTROKE Study, one of only three sites in Nigeria. And with an IBRO Research Fellowship in the Neurovascular Research Group of the Institute for Ageing and Health of the Newcastle University UK, Dr. Akinyemi is currently Project Leader and co-Principal Investigator of the COGFAST –Nigeria Study, the first systematic, comprehensive and longitudinal evaluation of cognitive dysfunction among stroke survivors in sub-Saharan Africa in collaboration with top-class researchers from Newcastle University, United Kingdom. COGFAST –NG aims to investigate the epidemiology, genetics and natural history of cognitive impairment in Nigerian stroke survivors.
Mayowa Owolabi, MBBS, MSc, received training in vascular neurology through a Deutscher Akademischer Austauschdienst, German Academic Exchange, sponsored scholarship which culminated in the award of a doctor of medicine degree by Charite Universitatsmedizin Berlin, Free University of Berlin and Humboldt University of Berlin. He also received training in epidemiology and global health from the University of Dundee-International Prevention Research Institute. Dr. Owolabi also received extensive training and certifications in research ethics. He won the 2008 American Academy of Neurology International Scholarship Award. He has more than twelve years’ experience in collaborative studies including ones at Germany, Canada, and UCLA in vascular neurology which includes investigations of risk factors for stroke and stroke prevention with the INTERSTROKE Study.